Bioethics

Article information
Title: Ethical Issues Related to the Use of GLP-1 Receptor Agonists Such as Ozempic and Mounjaro: Impact on Individuals and Society at Large
PubMed ID: 41353657

First Author Last Name: Minerva 

Abstract:
This paper explores the ethical implications of emerging weight-loss medications such as Semaglutide (Ozempic) and Tirzepatide (Mounjaro), analysing their therapeutic applications for obesity and potential use as enhancement drugs. These medications promise significant benefits, including improved individual health outcomes, reduced healthcare costs and, potentially, reduced environmental harms. However, their widespread adoption raises various concerns, such as unknown long-term side effects, the exacerbation of weight-based discrimination, and the reinforcement of socioeconomic disparities. The paper argues that, with robust regulatory frameworks in place, the potential benefits of these medications are likely to outweigh the risks. Nonetheless, ongoing monitoring of their effect on individuals and society at large remains essential.

Annotation
The finding:
This narrative review begins with a basic overview of obesity and GLP-1 receptor agonists, including their recognized and potential benefits and their known risks, acknowledging that little is known about long-term side effects of these medications. Key considerations that are reviewed include concerns about cost-effectiveness of the medications, the potential for abuse or for triggering anorexia nervosa in susceptible individuals, and their use for non-therapeutic enhancement purposes. The author expands discussion of GLP-1s for enhancement to discuss ethical concerns about medication shortages and the questionable risk/benefit ratio in this subgroup, especially when long term risks are unknown.
The article also examines population-level ethical considerations of the GLP-1s, including concerns that they may deepen social inequalities, exacerbate fatphobia, create social pressure for individuals to take the medications, and further increase stigma toward people who choose not to take them. The author also considers potential societal benefits of GLP-1s including reduced health care costs, decreased meat consumption, and reduced CO2 emissions.

Strength and weaknesses:
This paper is a narrative review that considers both individual- and population-level considerations, with attention to both benefits and harms. The primary weakness is that the review is not systematic. Overall, the author takes the stance that the benefits of these medications likely outweigh the harms, which may overstate the benefits, as other important considerations or perspectives may not have been included and because long terms risks are still unknown.

Relevance:
GLP-1 receptor agonists are widely prescribed, and CL psychiatrists will see an increasing number of patients on these medications. CL Psychiatrists will benefit from a basic understanding of the potential risks, benefits, and ethical dilemmas related to their use, particularly as they relate to eating disorders and mental health outcomes. Additionally, greater understanding of the interactions between GLP-1s and fatphobia, the body positivity movement, and social inequalities is important for increasing sensitivity and nuance to conversations around these medications.

Article information
Title: Structures of Safety in Hospital Disposition: Five Ethical Responsibilities.
PubMed ID: 40354188
First Author Last Name: Campelia

Abstract:
Complex hospital disposition is categorized by the difficulty or impossibility, despite efforts, to secure a medically safe discharge option for a patient. Discharge planning should negotiate limited inpatient resources that must be distributed justly, while also considering failures of outpatient and social resources to meet the patient's needs. This essay argues that recognition of these structural insufficiencies, which are inequitably distributed, must be a starting point for addressing safe hospital disposition. This recognition grounds five ethical responsibilities for navigating complex disposition planning: justice, common good, respect for persons, harm reduction, and care. Each responsibility is applied to common complex disposition vignettes, with attention to practical guidelines for implementation in clinical spaces.

Annotation

The finding:
The authors begin with laying out the challenges in hospital disposition in situations where social factors preclude the ideal discharge plan. They discuss the concept of a “medically safe” discharge and point out that what “safe” means depends on the perspective of the clinician/hospital and their risk tolerance. A framework of guiding questions is presented for what hospital teams can ask themselves to ensure they have done all possible to manage three categories of safety in complex dispositions: behavioral safety, social safety, and environmental safety. Using two sample case vignettes, the authors argue that hospitals bear the burden of inadequate societal resources for supporting patients’ medical safety in the community. They posit that hospitals’ goals in these situations should be an “adequate” safe discharge rather than an optimal one. They then provide an ethical framework for assessing what constitutes an “adequate” safe discharge, including five moral responsibilities: justice, common good, respect for persons, harm reduction, and care, with related guiding questions hospital teams can consider for each principle. They acknowledge that when no safe discharge options exist in the community, the hospital can become “forced to serve as a place of safety,” such as in a patient who has been banned from all local dialysis centers. They recommend interdisciplinary committees review complex disposition cases as a means of alleviating the moral distress of clinicians who care for patients where an ideal safe discharge cannot be secured due to societal failures.

Strength and weaknesses:
A major strength is that this paper offers a systematic framework for how hospitals and the teams working in them can provide an “adequate” medically safe discharge within the structural limitations in surrounding communities. The paper further provides a cogent and pragmatic analysis of ethical discharge planning that can alleviate moral distress among clinicians about the imperfect options they face in complex dispositions. As the paper is an ethics analysis, not a scientific article, weaknesses are a subjective question. Empirical data would be useful in future studies on how use of Campelia et al.’s framework impacts outcomes such as moral distress of clinicians and post-discharge well-being of patients.

Relevance:
From the C-L psychiatry perspective, dispositional capacity consultations can serve as a way primary teams and hospitals transfer the moral burden for the safe discharge onto the consulting psychiatrist in these cases. Ways to navigate that are discussed by a C-L psychiatrist in an open peer commentary in response to the original article (Sahota PKC. Capacity Consultations and Moral Responsibility for the Safe Disposition. Am J Bioeth. 2026 Jun;26(6):83-85. doi: 10.1080/15265161.2026.2657890. Epub 2026 May 18. PMID: 42149518). Campelia et al.’s ethical framework can be used by C-L psychiatrists as a guide for when they support primary teams and hospitals through what constitutes an adequate safe discharge. Convening multidisciplinary committees (including ethics, legal, risk management, discharge planning, multiple medical specialties, and nursing) is a helpful approach suggested by Campelia et al and Sahota as a means of sharing moral responsibility for what constitutes a “safe discharge” such that no one clinician or health care team member carries undue moral burden and distress.